Form 4 for IART INTEGRA LIFESCIENCES HOLDINGS CORP
Accepted 2023-01-19 00:00:00 ET · period of report 2023-01-18 · accession 0001209191-23-004012 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-01-19 | 2023-01-18 | IART | De Witte Jan | Pres, CEO, Dir | F - Tax | $54.78 | -431 | 0 | -100% | -$23.6K |
| D | 2023-01-19 | 2023-01-18 | IART | De Witte Jan | Pres, CEO, Dir | M - OptEx | $0.00 | +431 | 431 | New | $0 |
| D | 2023-01-19 | 2023-01-18 | IART | De Witte Jan | Pres, CEO, Dir | M - OptEx | $0.00 | -431 | 74.0K | -0.6% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-01-18 | F | D | 431 | $54.78 | 0 | D | — | — | |
| 2 | Common | Common Stock | 2023-01-18 | M | A | 431 | $0.00 | 431 | D | — | — | |
| 3 | Derivative | Restricted Stock Units | 2023-01-18 | M | D | 431 | $0.00 | 74,025 | D | $0.00 · — to — | 431 Common Stock | (F1) The award was a restricted stock unit award which vests in three annual equal installments on the first, second and third anniversaries of the grant date of 1/18/2022 of which the first installment vested on 1/18/2023 and which shall be delivered to Mr. De Witte within 30 days following the first business day that occurs immediately following the six-month period after the date of his separation of service as deferred compensation. |